Binary and Tertiary Mixtures of Satureja hortensis and Origanum vulgare Essential Oils as Potent Antimicrobial Agents Against Helicobacter pylori.
Lesjak M1, Simin N1, Orcic D1, Franciskovic M1, Knezevic P2, Beara I1, Aleksic V2, Svircev E1, Buzas K3,4, Mimica-Dukic N1
1Department of Chemistry, Biochemistry and Environmental Protection, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovica 3, 21000, Novi Sad, Vojvodina, Serbia.
2Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovica 2, 21000, Novi Sad, Vojvodina, Serbia.
3Tumorimmunology and Pharmacology Research Group, Institute of Biochemistry, Biological Research Centre, Temesvari krt. 62, H-6726, Szeged, Hungary.
4Faculty of Dentistry, University of Szeged, Tisza Lajos krt. 64., H-6720, Szeged, Hungary.
Essential oils possess strong antimicrobial activity, even against multiresistant Helicobacter pylori. Available therapies against H. pylori infection have multiple disadvantages, indicating a great need for a development of new therapeutics. The purpose of this study was to develop a potent natural product based anti-H. pylori formulation. First, anti-H. pylori activity of nine essential oils was determined, after which the most active oils were mixed in various ratios for further testing. Satureja hortensis, Origanum vulgare subsp. vulgare and O. vulgare subsp. hirtum essential oils expressed the highest activity (MIC = 2 μL mL(-1) ). Their binary and ternary mixtures exhibited notably higher antimicrobial activity (MIC ≤ 2 μL mL(-1) ). The most active was the mixture of S. hortensis and O. vulgare subsp. hirtum oils in volume ratio 2:1, which expressed 4 times higher activity than individual oils (MIC = 0.5 μL mL(-1) ). According to GC-MS, both oils in the mixture were characterized by high content of phenols (48-73%), with carvacrol as the main carrier of antimicrobial activity. Presented in vitro study pointed out binary mixture of S. hortensis and O. vulgare subsp. hirtum essential oils in volume ratio 2:1 as promising candidate for further in vivo studies targeting H. pylori infection.
You Can Read the Medical Study Here.
Copyright © 2015 John Wiley & Sons, Ltd.